Genetic Alterations Promoting Alcohol Induced Hepatic Carcinogenesis

基因改变促进酒精诱发的肝癌发生

基本信息

  • 批准号:
    8326615
  • 负责人:
  • 金额:
    $ 22.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Chronic liver damage caused by chronic intake of alcohol and hepatitis viral infections is a major risk factor for HCC pathogenesis. In particular, there is compelling evidence that alcohol consumption and HCV infection synergistically induce liver damage, which culminates in an increased incidence of HCC. Molecular analyses and animal modeling have demonstrated that alcohol, with or without HCV infection, is not sufficient to induce HCC in vivo. It is believed that alcoholic liver disease (ALD), especially when accompanied by HCV infection, provides an environment that predisposes to HCC development. However, additional genetic mutations are required to transform the hepatocytes into malignant cells and induce liver tumor formation. In the present application, we hypothesize that certain genetic events, such as c-Myc or c-Met overexpression will lead to HCC formation in chronic alcohol fed mice and/or alcohol fed HCV Ns5a Transgenic (Ns5aTg) mice. In addition, we also hypothesize that chronic alcohol feeding will accelerate tumor growth induced by combination of oncogenes. To test these hypotheses, we propose the following two aims. In Aim One, we will determine whether c-Myc or c-Met overexpression leads to hepatic carcinogenesis in chronic alcohol fed wildtype mice or chronic alcohol fed HCV Ns5aTg mice. And in Aim Two, we will determine whether chronic alcohol feeding accelerates liver tumor growth induced by c-Met/CCND1 or c-Met/Spry2Y55F. Once we are able to establish HCC tumor models for ALD or ALD/HCV mice, we will further characterize the molecular, genetic and biochemical features as well as epigenetic modifications in the tumor tissues. Altogether, the proposed studies will assist to identify important driver oncogenes that have critical roles during liver cancer pathogenesis, and provide novel insight into the molecular mechanisms of HCC development in the context of alcohol induced liver injury. The novel mouse models established in the study will be of great usefulness to further characterize therapeutic interventions to prevent or treat hepatic carcinogenesis in patients with ALD.
描述(由申请人提供):肝细胞癌(HCC)是全球癌症相关死亡的主要原因之一。慢性酒精摄入和肝炎病毒感染引起的慢性肝损伤是HCC发病的主要危险因素。特别是,有令人信服的证据表明,饮酒和HCV感染协同诱导肝损伤,最终导致HCC发病率增加。分子分析和动物模型表明,无论是否有HCV感染,酒精都不足以在体内诱导HCC。人们认为酒精性肝病(ALD),特别是伴随HCV感染时,提供了一个易发生HCC的环境。然而,需要额外的基因突变才能将肝细胞转化为恶性细胞并诱导肝肿瘤的形成。在目前的应用中,我们假设某些遗传事件,如c-Myc或c-Met过表达会导致慢性酒精喂养小鼠和/或酒精喂养HCV Ns5a转基因(Ns5aTg)小鼠的HCC形成。此外,我们还假设慢性酒精喂养会加速癌基因联合诱导的肿瘤生长。为了验证这些假设,我们提出了以下两个目标。在Aim 1中,我们将确定c-Myc或c-Met过表达是否会导致慢性酒精喂养野生型小鼠或慢性酒精喂养HCV Ns5aTg小鼠的肝癌发生。在第二阶段,我们将确定慢性酒精喂养是否会加速c-Met/CCND1或c-Met/Spry2Y55F诱导的肝脏肿瘤生长。一旦我们能够建立ALD或ALD/HCV小鼠的HCC肿瘤模型,我们将进一步表征肿瘤组织中的分子、遗传和生化特征以及表观遗传修饰。总之,这些研究将有助于确定在肝癌发病过程中起关键作用的重要驱动癌基因,并为酒精性肝损伤背景下HCC发展的分子机制提供新的见解。该研究建立的新型小鼠模型将对进一步表征治疗干预措施以预防或治疗ALD患者的肝癌发生具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xin Chen其他文献

Xin Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xin Chen', 18)}}的其他基金

Investigating multifactorial beta-catenin activation in hepatocellular cancers
研究肝细胞癌中的多因素 β-连环蛋白激活
  • 批准号:
    10541171
  • 财政年份:
    2022
  • 资助金额:
    $ 22.21万
  • 项目类别:
Investigating multifactorial beta-catenin activation in hepatocellular cancers
研究肝细胞癌中的多因素 β-连环蛋白激活
  • 批准号:
    10574374
  • 财政年份:
    2022
  • 资助金额:
    $ 22.21万
  • 项目类别:
Signaling pathways during hepatocarcinogenesis
肝癌发生过程中的信号通路
  • 批准号:
    10636858
  • 财政年份:
    2022
  • 资助金额:
    $ 22.21万
  • 项目类别:
Signaling pathways during hepatocarcinogenesis
肝癌发生过程中的信号通路
  • 批准号:
    10570081
  • 财政年份:
    2022
  • 资助金额:
    $ 22.21万
  • 项目类别:
Investigating multifactorial beta-catenin activation in hepatocellular cancers
研究肝细胞癌中的多因素 β-连环蛋白激活
  • 批准号:
    10326862
  • 财政年份:
    2021
  • 资助金额:
    $ 22.21万
  • 项目类别:
Cabozentinib based combination therapy for the treatment of hepatocellular carcinoma
基于卡博替尼的联合疗法治疗肝细胞癌
  • 批准号:
    10117217
  • 财政年份:
    2020
  • 资助金额:
    $ 22.21万
  • 项目类别:
Signaling pathways during hepatocarcinogenesis
肝癌发生过程中的信号通路
  • 批准号:
    9906655
  • 财政年份:
    2020
  • 资助金额:
    $ 22.21万
  • 项目类别:
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma
癌症相关成纤维细胞在胆管癌中的作用
  • 批准号:
    10166796
  • 财政年份:
    2018
  • 资助金额:
    $ 22.21万
  • 项目类别:
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma
癌症相关成纤维细胞在胆管癌中的作用
  • 批准号:
    10414782
  • 财政年份:
    2018
  • 资助金额:
    $ 22.21万
  • 项目类别:
Inducible systems for studying liver tumor mainenance in vivo
用于研究肝脏肿瘤体内维持的诱导系统
  • 批准号:
    9457376
  • 财政年份:
    2017
  • 资助金额:
    $ 22.21万
  • 项目类别:

相似海外基金

Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
  • 批准号:
    10019450
  • 财政年份:
    2019
  • 资助金额:
    $ 22.21万
  • 项目类别:
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
  • 批准号:
    9896234
  • 财政年份:
    2019
  • 资助金额:
    $ 22.21万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    7990196
  • 财政年份:
    2010
  • 资助金额:
    $ 22.21万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8299173
  • 财政年份:
    2010
  • 资助金额:
    $ 22.21万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8102173
  • 财政年份:
    2010
  • 资助金额:
    $ 22.21万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8494464
  • 财政年份:
    2010
  • 资助金额:
    $ 22.21万
  • 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
  • 批准号:
    8693870
  • 财政年份:
    2010
  • 资助金额:
    $ 22.21万
  • 项目类别:
Screening of food components for the prevention of alcoholic liver diseases and their application
预防酒精性肝病的食品成分筛选及其应用
  • 批准号:
    21500783
  • 财政年份:
    2009
  • 资助金额:
    $ 22.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of transforming growth factor-a to thr development of hepatic fibrosis in alcoholic liver diseases
转化生长因子-a对酒精性肝病肝纤维化发展的贡献
  • 批准号:
    09670560
  • 财政年份:
    1997
  • 资助金额:
    $ 22.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immunological mechanism on the generation of alcoholic liver diseases
酒精性肝病发生的免疫学机制
  • 批准号:
    03670349
  • 财政年份:
    1991
  • 资助金额:
    $ 22.21万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了